# Contact MD Retatrutide

> Contact the MD Retatrutide editorial team — corrections, citation questions, or editorial correspondence. Not a clinical contact; medical questions should go to a licensed provider.

Editorial correspondence only. This is not a clinic and we cannot respond to medical or clinical questions.

## Editorial contact

MD Retatrutide is an independent editorial project. We read and respond to editorial correspondence: factual corrections, citation questions, requests to update information based on newly published research, and general questions about what this site covers.

We do not provide medical advice, dosing guidance, or clinical consultations. We are not a clinic, pharmacy, or healthcare provider. If you have a medical question, please consult a licensed healthcare professional.

If you believe a citation on this site is incorrect — wrong DOI, misattributed finding, outdated information — we want to know. Accurate attribution to the published record is the editorial standard this site holds itself to. Use the contact form below and include the page URL and the specific claim in question.

For information about participating in active retatrutide clinical trials, ClinicalTrials.gov lists the TRIUMPH program with eligibility criteria and site contact information.

## Send a message

Use the form below for editorial correspondence. Response times are typically 5-10 business days.

[Contact form — name, email, subject, message — rendered by the assembler]

---

A measured reading of the retatrutide trial record — the Phase 2 endpoints set down and cited, the Phase 3 program noted as open, and nothing here prescribed, dispensed, or sold.